PT2076502E - Carboxamidas substituídas - Google Patents

Carboxamidas substituídas

Info

Publication number
PT2076502E
PT2076502E PT07873705T PT07873705T PT2076502E PT 2076502 E PT2076502 E PT 2076502E PT 07873705 T PT07873705 T PT 07873705T PT 07873705 T PT07873705 T PT 07873705T PT 2076502 E PT2076502 E PT 2076502E
Authority
PT
Portugal
Prior art keywords
group
receptor antagonists
metabotropic receptor
substituted carboxamides
substituted
Prior art date
Application number
PT07873705T
Other languages
English (en)
Inventor
Kumiko Takeuchi
Matthew Joseph Fisher
Edward C R Smith
Ryan Thomas Backer
Steven Lee Kuklish
Sean Patrick Hollinshead
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT2076502E publication Critical patent/PT2076502E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT07873705T 2006-06-08 2007-06-07 Carboxamidas substituídas PT2076502E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81183906P 2006-06-08 2006-06-08

Publications (1)

Publication Number Publication Date
PT2076502E true PT2076502E (pt) 2011-06-07

Family

ID=39673278

Family Applications (1)

Application Number Title Priority Date Filing Date
PT07873705T PT2076502E (pt) 2006-06-08 2007-06-07 Carboxamidas substituídas

Country Status (31)

Country Link
US (1) US7960419B2 (pt)
EP (1) EP2076502B1 (pt)
JP (1) JP5108878B2 (pt)
KR (1) KR101051559B1 (pt)
CN (1) CN101466691B (pt)
AT (1) ATE509921T1 (pt)
AU (1) AU2007347428B2 (pt)
BR (1) BRPI0712862A2 (pt)
CA (1) CA2652074C (pt)
CR (1) CR10410A (pt)
CY (1) CY1111588T1 (pt)
DK (1) DK2076502T3 (pt)
EA (1) EA014233B1 (pt)
EC (1) ECSP088939A (pt)
ES (1) ES2362949T3 (pt)
HK (1) HK1131984A1 (pt)
HR (1) HRP20110436T1 (pt)
IL (1) IL195632A (pt)
MA (1) MA30620B1 (pt)
MX (1) MX2008015485A (pt)
MY (1) MY148084A (pt)
NO (1) NO341474B1 (pt)
NZ (1) NZ573352A (pt)
PL (1) PL2076502T3 (pt)
PT (1) PT2076502E (pt)
RS (1) RS51818B (pt)
SI (1) SI2076502T1 (pt)
TN (1) TNSN08506A1 (pt)
UA (1) UA95480C2 (pt)
WO (1) WO2008103185A2 (pt)
ZA (1) ZA200809111B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0804685D0 (en) 2008-03-13 2008-04-16 Univ Edinburgh Therapeutic compounds and their use
PL2276759T3 (pl) 2008-04-04 2012-03-30 Lilly Co Eli 3-indazolilo-4-pirydyloizotiazole
WO2010146338A1 (en) * 2009-06-15 2010-12-23 The University Of Edinburgh Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metabolic syndrome and related disorders
ES2540547T3 (es) 2009-09-16 2015-07-10 The University Of Edinburgh Compuestos de (4-fenil-piperidin-1-il)-[5-(1H-pirazol-4-il)-tiofen-3-il]-metanona y su uso
DK2563780T3 (en) 2010-04-29 2015-07-27 Univ Edinburgh 3,3-DISUBSTITUEREDE- (8-aza-bicyclo [3.2.1] oct-8-yl) - [5- (1H-pyrazol-4-yl) -thiophene-3-yl] -METHANONER as inhibitors of 11 ( BETA) -HSD1
NO2921489T3 (pt) 2012-11-13 2018-02-03
JP2019529452A (ja) 2016-09-23 2019-10-17 バイエル・アクチエンゲゼルシヤフト Ｎ３−環状置換チエノウラシルおよびその使用
CN117567266B (zh) * 2023-11-07 2024-06-14 康龙化成手性医药技术(宁波)有限公司 一种制备2-甲基环丙羧酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL72091A0 (en) * 1983-06-20 1984-10-31 Lilly Co Eli N'-substituted(3-aryl 5-isothiazolyl)urea derivatives
DE4328425A1 (de) 1993-08-24 1995-03-02 Basf Ag Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung
DK124393D0 (da) * 1993-11-03 1993-11-03 Lundbeck & Co As H Compounds
DE19542372A1 (de) * 1995-11-14 1997-05-15 Bayer Ag Acylierte 5-Aminoisothiazole
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
JP3411262B2 (ja) * 1999-08-20 2003-05-26 萬有製薬株式会社 新規スピロ化合物
EP1435948A1 (en) * 2001-08-06 2004-07-14 Pharmacia Italia S.p.A. Aminoisoxazole derivatives active as kinase inhibitors
EP1667983A4 (en) * 2003-09-23 2010-07-21 Merck Sharp & Dohme PYRAZOL MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
CN1984899B (zh) * 2004-05-12 2011-07-27 先灵公司 Cxcr1和cxcr2趋化因子拮抗剂
BRPI0515571A (pt) * 2004-09-23 2008-07-29 Pfizer Prod Inc agonistas de receptor de trombopoetina

Also Published As

Publication number Publication date
JP2009539874A (ja) 2009-11-19
UA95480C2 (uk) 2011-08-10
ATE509921T1 (de) 2011-06-15
ECSP088939A (es) 2009-01-30
ES2362949T3 (es) 2011-07-15
CA2652074C (en) 2013-08-06
CR10410A (es) 2008-11-28
MX2008015485A (es) 2009-03-06
HK1131984A1 (en) 2010-02-12
WO2008103185A2 (en) 2008-08-28
NZ573352A (en) 2011-10-28
NO20085028L (no) 2008-12-02
EP2076502B1 (en) 2011-05-18
NO341474B1 (no) 2017-11-27
US20090182025A1 (en) 2009-07-16
RS51818B (en) 2011-12-31
PL2076502T3 (pl) 2011-09-30
IL195632A0 (en) 2009-09-01
AU2007347428B2 (en) 2012-02-09
DK2076502T3 (da) 2011-07-25
CN101466691A (zh) 2009-06-24
EA200870516A1 (ru) 2009-06-30
MY148084A (en) 2013-02-28
CA2652074A1 (en) 2008-08-28
IL195632A (en) 2013-11-28
WO2008103185A3 (en) 2008-10-30
HRP20110436T1 (hr) 2011-08-31
TNSN08506A1 (en) 2010-04-14
EA014233B1 (ru) 2010-10-29
CN101466691B (zh) 2011-07-27
MA30620B1 (fr) 2009-08-03
CY1111588T1 (el) 2015-10-07
SI2076502T1 (sl) 2011-09-30
AU2007347428A1 (en) 2008-08-28
BRPI0712862A2 (pt) 2012-12-18
KR20090008460A (ko) 2009-01-21
US7960419B2 (en) 2011-06-14
KR101051559B1 (ko) 2011-07-22
EP2076502A2 (en) 2009-07-08
ZA200809111B (en) 2009-12-30
JP5108878B2 (ja) 2012-12-26

Similar Documents

Publication Publication Date Title
HK1131984A1 (en) Substituted carboxamides as group i metabotropic receptor antagonists
IL184932A0 (en) Glucagon receptor antagonists, preperation and therapeutic uses
PL1735278T3 (pl) Związki receptora histaminowego H3, wytwarzanie i zastosowania terapeutyczne
WO2008032191A3 (en) Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
MX361542B (es) Compuestos de morfinan.
UA86621C2 (ru) Антагонисты рецептора глюкагона, их получение и терапевтическое применение
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
UA92670C2 (ru) Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе
MX2009000900A (es) Derivados de imidazolonas sustituidas, preparacion y usos.
MY154591A (en) Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor
MX2010002584A (es) Derivados de piperidina como agonistas de receptores muscarinicos.
MX2010009395A (es) Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y procesos para preparacion de los mismos.
MX2012001160A (es) Agonistas del receptor de esfingosina-1-fosfato.
PT1861360E (pt) Derivados de pirrolidina como antagonistas de receptores h3 de histamina
TW200806321A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
PL1805169T3 (pl) Inhibitory receptora histaminowego H3, ich wytwarzanie i zastosowania terapeutyczne
NZ598783A (en) Use of opioid receptor antagonist for gastrointestinal tract disorders
WO2007145563A8 (en) Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
EA015500B9 (ru) Новые антагонисты мсн рецепторов